<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326544</url>
  </required_header>
  <id_info>
    <org_study_id>MS/17.07.80</org_study_id>
    <nct_id>NCT03326544</nct_id>
  </id_info>
  <brief_title>Saphenous Nerve Block Versus Platelet Rich Plasma for Chronic Knee Osteoarthritis</brief_title>
  <official_title>Ultra-sound Guided Saphenous Nerve Block Versus Platelet Rich Plasma for Chronic Knee Joint Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Knee osteoarthritis, as a progressive disease is one of the most common causes of pain, motor&#xD;
      disorder and disability in the elderly. By increasing age, the cartilage is eroded and&#xD;
      endures degenerative changes due to physiological and biomechanical changes as well as&#xD;
      metabolic effects and trauma . Non-surgical interventions for pain control of knee&#xD;
      osteoarthritis include weight loss, exercise, changes in daily activities, physiotherapy,&#xD;
      nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics .However ,the intra-articular&#xD;
      injection is recently recommended by many studies such as corticosteroids, hyaluronic acid,&#xD;
      Growth hormone, dextrose ,and platelet rich plasma.&#xD;
&#xD;
      Intra-articular injection of platelets are activated and undergo degranulation, releasing a&#xD;
      range of growth factors, including transforming growth factor beta (TGF-Î²), platelet-derived&#xD;
      growth factor (PDGF), insulin-like growth factor, vascular endothelial growth factors,&#xD;
      epidermal growth factors and basic fibroblast growth factor 2. These growth factors are&#xD;
      thought to activate a variety of signaling pathways, which promote healing of bone and soft&#xD;
      tissue.Also,some minimally invasive therapeutic options have been effective in pain relieve&#xD;
      in KA, such as ultrasound-guided saphenous nerve block .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the efficacy of ultrasound guided saphenous nerve block&#xD;
      versus platelet rich plasma injection in the management of chronic pain in patients with knee&#xD;
      OA. This study will be conducted to evaluate which modality is more effective.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores</measure>
    <time_frame>For 6 months after intervention</time_frame>
    <description>The severity of pain will be assessed using a visual analog scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QOL)</measure>
    <time_frame>For 6 months after intervention</time_frame>
    <description>is evaluated using the Western Ontario and MC Master universities (WOMAC) index of osteoarthritis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Chronic Knee Joint Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Saphenous nerve block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive ultrasound-guided intervention treatment with a sub-sartorial approach for a saphenous nerve block with 8 mL of bupivacaine 0.5% plus dexamethasone 4 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platelet rich plasma group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive intra-articular ultrasound-guided injection of 5 mL of autologous Platelet rich plasma</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saphenous nerve block group</intervention_name>
    <description>Patients will receive ultrasound-guided intervention treatment with a sub-sartorial approach for a saphenous nerve block with 8 mL of bupivacaine 0.5% plus dexamethasone 4 mg</description>
    <arm_group_label>Saphenous nerve block group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Platelet rich plasma group</intervention_name>
    <description>Patients will receive intra-articular ultrasound-guided injection of 5 mL of autologous Platelet rich plasma</description>
    <arm_group_label>Platelet rich plasma group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who are not competent to understand the study protocol&#xD;
&#xD;
          -  Radiographic evidence of OA of knee of 2nd degree.&#xD;
&#xD;
          -  Chronic pain for at least 6 months prior to study entry (day 0).&#xD;
&#xD;
          -  Pain relief not achieved with conservative therapies during the last 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Bleeding disorders.&#xD;
&#xD;
          -  Coagulation disorders.&#xD;
&#xD;
          -  Local skin infection&#xD;
&#xD;
          -  Current other problem in the affected extremity .&#xD;
&#xD;
          -  Psychiatric disorders affecting co-operation of the patient .&#xD;
&#xD;
          -  Previous chronic opioid use.&#xD;
&#xD;
          -  Intra articular knee injection within previous three months.&#xD;
&#xD;
          -  History of traumatic arthropathy.&#xD;
&#xD;
          -  History of neuropathic arthropathy.&#xD;
&#xD;
          -  Allergy or hypersensitivity to any of the study medication.&#xD;
&#xD;
          -  Any condition that could interfere with the interpretation of the outcome assessments.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Lactating women.&#xD;
&#xD;
          -  low back pain due to central cause.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mansoura University Hospitals</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 26, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

